The coronavirus disease 2019 outbreak is evolving rapidly worldwide. The lungs are the target of the primary infection and patients with lung cancer seem to have a poor prognosis. To our knowledge, this is the first reported investigation of a possible role of interleukin-17 target therapy in patients with lung cancer and concomitant severe acute respiratory syndrome–coronavirus-2 infection.
All Keywords
【저자키워드】 COVID-19, monoclonal antibody, lung cancer, IL-17 target therapy,
【저자키워드】 COVID-19, monoclonal antibody, lung cancer, IL-17 target therapy,